Kees de Joncheere

The role of drug regulatory authorities and health technology assessment agencies in shaping incentives for antibiotic R&D: a qualitative study

Challenges of e-Learning during the COVID-19 Pandemic Experienced by EFL Learners

Origin of Antibiotics and Antibiotic Resistance, and Their Impacts on Drug Development: A Narrative Review

Critical challenges and emerging opportunities in hepatitis C virus research in an era of potent antiviral therapy: Considerations for scientists and funding agencies

Calculation of the disease burden associated with environmental chemical exposures: application of toxicological information in health economic estimation

Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

Cost-Effectiveness Thresholds in Global Health: Taking a Multisectoral Perspective

The effect of the late 2000s financial crisis on suicides in Spain: an interrupted time-series analysis

Interrupted time series regression for the evaluation of public health interventions: a tutorial

Multi-input chemical control of protein dimerization for programming graded cellular responses

Status of Direct-Acting Antiviral Therapy for Hepatitis C Virus Infection and Remaining Challenges

Addressing the challenge of high-priced prescription drugs in the era of precision medicine: A systematic review of drug life cycles, therapeutic drug markets and regulatory frameworks

A new framework for developing and evaluating complex interventions: update of Medical Research Council guidance

Hepatitis C Virus: 30 Years after Its Discovery

Taming a beast: lessons from the domestication of hepatitis C virus

Outside the Safe Operating Space of the Planetary Boundary for Novel Entities

Managing pharmaceutical shortages: an overview and classification of policy responses in Europe and the USA

Protease inhibitor therapy for hepatitis C virus-infection

Cost-effectiveness of cervical cancer screening methods in low- and middle-income countries: A systematic review

A Recombinant Hepatitis C Virus Genotype 1a E1/E2 Envelope Glycoprotein Vaccine Elicits Antibodies That Differentially Neutralize Closely Related 2a Strains through Interactions of the N-Terminal Hypervariable Region 1 of E2 with Scavenger Receptor B1

Replicons of a Rodent Hepatitis C Model Virus Permit Selection of Highly Permissive Cells

Internal Disequilibria and Phenotypic Diversification during Replication of Hepatitis C Virus in a Noncoevolving Cellular Environment

Cost–effectiveness thresholds: pros and cons

Pharmaceutical policies in European countries in response to the global financial crisis

Prices, Costs, and Affordability of New Medicines for Hepatitis C in 30 Countries: An Economic Analysis

Pharmaceutical policies in a crisis? Challenges and solutions identified at the PPRI Conference

How Can Pricing and Reimbursement Policies Improve Affordable Access to Medicines? Lessons Learned from European Countries

Effect of the economic recession on pharmaceutical policy and medicine sales in eight European countries